MBH on Valstar and Kemiphadrm stake sale

Matouk Bassiouny & Hennawy (MBH) advised Valstar Investment on the sale of the entire stake in Luxembourg-based Valstar (“Valstar”), as well as in Kemipharm (“Kemipharm”) a manufacturer of tablets and capsules based in Morocco, to Sun Pharma for approximately USD 31 million.

Founding partner and group head of corporate and M&A Omar S. Bassiouny (pictured) led the team, which included counsel Ossama Abouzaid. Ascent Capital also acted as financial advisor to Valstar Investment.